Dental Pro

Description

The provided data does not specify the chemical name, physical characteristics, or inactive ingredients of the drug. Therefore, a detailed description cannot be formulated based on the available information. Further details are required to create a comprehensive description section.

Uses and Indications

This drug is indicated for oral hygiene by sterilizing the mouth.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication is intended for oral administration. Healthcare professionals should ensure that patients are instructed to take the medication as prescribed, adhering to the recommended dosing guidelines.

Dosing ranges and intervals should be determined based on the specific clinical scenario and patient characteristics. It is essential to monitor the patient's response to therapy and adjust the dosage as necessary to achieve optimal therapeutic outcomes.

Prior to administration, healthcare providers should verify that the patient is able to swallow the medication safely. If applicable, the medication may be taken with or without food, but consistency in the method of administration is advised to maintain stable drug levels in the body.

Patients should be counseled on the importance of adhering to the prescribed dosing schedule and to report any adverse effects or concerns to their healthcare provider promptly.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

It is imperative that the product is not swallowed, as this poses significant health risks. Healthcare professionals should ensure that patients are adequately informed about this critical warning to prevent accidental ingestion.

Currently, there are no additional general precautions or relevant laboratory tests associated with the use of this product. Therefore, it is essential for healthcare providers to remain vigilant and monitor patients for any unusual symptoms or adverse reactions that may arise during treatment.

In the event of an emergency, it is crucial for patients to seek immediate medical assistance. Healthcare professionals should emphasize the importance of prompt action in such situations.

Should any concerning symptoms develop, patients are advised to discontinue use of the product and consult their healthcare provider for further guidance. It is the responsibility of healthcare professionals to communicate these instructions clearly to ensure patient safety.

Side Effects

Patients should be advised not to swallow the medication, as this may lead to unintended consequences. No specific side effects or adverse reactions have been reported in clinical trials or postmarketing experiences. It is important for healthcare providers to monitor patients for any unexpected reactions during treatment, given the absence of documented adverse effects.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Dental Pro (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. It is essential to ensure that the medication is stored safely to prevent accidental ingestion or misuse.

Geriatric Use

Elderly patients may use DENTAL PRO - sodium fluoride mouthwash; however, the drug insert does not provide specific information regarding geriatric use, dosage adjustments, safety concerns, or special precautions for this population.

Healthcare providers should exercise caution when prescribing this mouthwash to geriatric patients, considering the absence of tailored guidance. Monitoring for any adverse effects or unusual responses in elderly patients is advisable, given the lack of specific data.

Pregnancy

There is no specific information regarding the use of DENTAL PRO - sodium fluoride mouthwash in pregnant patients. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for use during pregnancy. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes. It is recommended that pregnant patients consult their healthcare provider for personalized guidance regarding the use of this product during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment may require dosage adjustments to ensure safety and efficacy. It is essential to monitor renal function tests in these individuals to assess their kidney status. Additionally, a reduced dose should be considered for patients with decreased creatinine clearance to mitigate the risk of adverse effects associated with impaired renal function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage and handling to ensure the safety of young children.

Storage and Handling

This product is supplied in a configuration suitable for oral administration. It is essential to keep this product out of reach of children to ensure safety. Users are advised not to swallow the product.

Storage conditions should be adhered to strictly to maintain product integrity. Specific temperature ranges and container requirements are not provided; however, general best practices for storage should be followed. Special handling needs should be observed to ensure the product remains effective and safe for use.

Additional Clinical Information

The product is administered via the dental route. Clinicians should advise patients to keep the product out of reach of children. For proper use, patients should turn the container cap to open it, pour approximately 10-15 ml of The Gargle into the cap without overflowing, and then place it in the mouth. Patients are instructed to gargle thoroughly for about 10 seconds. Following gargling, to ensure mouth sterilization, the liquid should be held in the mouth for about 30 seconds before spitting it out; swallowing is not recommended.

Drug Information (PDF)

This file contains official product information for Dental Pro, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)